Concepedia

Christos Emmanouilides

CE

48

Publications

7.5K

Citations

37

H-Index

1994

Active since

Affiliations

University of California, Los Angeles(Current)

Northwestern University

Mayo Clinic

Dana-Farber Cancer Institute

Interbalkan Medical Center

Christos Emmanouilides is an author at University of California, Los Angeles specializing in medicine, immunology, and oncology.

Top concepts

Publications per year

1994–2019

48

Publications

48

Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma

Thomas E. Witzig, Leo I. Gordon, Fernando Cabanillas et al. · Journal of Clinical Oncology · 2002 · 1.2K citations

Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

Ricardo Spielberger, Patrick J. Stiff, William Bensinger et al. · New England Journal of Medicine · 2004 · 890 citations

Treatment With Ibritumomab Tiuxetan Radioimmunotherapy in Patients With Rituximab-Refractory Follicular Non-Hodgkin’s Lymphoma

Thomas E. Witzig, Ian W. Flinn, Leo I. Gordon et al. · Journal of Clinical Oncology · 2002 · 649 citations

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20<sup>+</sup>B-Cell Non-Hodgkin's Lymphoma

Thomas E. Witzig, Christine A. White, Gregory A. Wiseman et al. · Journal of Clinical Oncology · 1999 · 538 citations

Safety of Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma

Thomas E. Witzig, Christine A. White, Leo I. Gordon et al. · Journal of Clinical Oncology · 2003 · 290 citations

Rows per page

1–5 of 48